Correlation Between Quest Diagnostics and Sanara Medtech

Can any of the company-specific risk be diversified away by investing in both Quest Diagnostics and Sanara Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest Diagnostics and Sanara Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quest Diagnostics Incorporated and Sanara Medtech, you can compare the effects of market volatilities on Quest Diagnostics and Sanara Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest Diagnostics with a short position of Sanara Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest Diagnostics and Sanara Medtech.

Diversification Opportunities for Quest Diagnostics and Sanara Medtech

0.04

Correlation Coefficient

Quest Diagnostics  Sanara Medtech

Significant diversification

The 3 months correlation between Quest and Sanara is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Quest Diagnostics Incorporated and Sanara Medtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanara Medtech and Quest Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest Diagnostics Incorporated are associated (or correlated) with Sanara Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanara Medtech has no effect on the direction of Quest Diagnostics i.e., Quest Diagnostics and Sanara Medtech go up and down completely randomly.

Pair Corralation between Quest Diagnostics and Sanara Medtech

Considering the 90-day investment horizon Quest Diagnostics Incorporated is expected to generate 0.54 times more return on investment than Sanara Medtech. However, Quest Diagnostics Incorporated is 1.86 times less risky than Sanara Medtech. It trades about 0.12 of its potential returns per unit of risk. Sanara Medtech is currently generating about 0.0 per unit of risk. If you would invest  15,227  in Quest Diagnostics Incorporated on December 25, 2024 and sell it today you would earn a total of  1,506  from holding Quest Diagnostics Incorporated or generate 9.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Quest Diagnostics Incorporated  vs.  Sanara Medtech

Quest Diagnostics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Quest Diagnostics Incorporated are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Quest Diagnostics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Sanara Medtech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sanara Medtech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Sanara Medtech is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Quest Diagnostics and Sanara Medtech

The main advantage of trading using opposite Quest Diagnostics and Sanara Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest Diagnostics position performs unexpectedly, Sanara Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanara Medtech will offset losses from the drop in Sanara Medtech's long position.

The idea behind Quest Diagnostics Incorporated and Sanara Medtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.